Welcome!
Welcome to HDMAVotes, a new, interactive tool that provides information to HDMA members on upcoming local and national elections. The information provided is non-partisan and provides direct links to the candidates’ web sites and contact information.
Through this site, you can find out about voter registration, learn more about the candidates running for election in your area, locate your local polling place, and learn how to obtain an absentee ballot by clicking “Voter Resources” at the right. You can also find out more about the critical issues that affect the pharmaceutical distribution industry and take action by contacting your Congressman or Senator when necessary.
It is critical to the healthcare distribution industry’s continued legislative success that we work to elect members of Congress that support the interests of our industry on behalf of patient safety and supply chain integrity.
To participate, you will be asked to register once and provide your home location. This allows HDMAVotes to correctly match you with your elected officials and help you with voter registration. You can also learn about candidates’ positions on key issues that affect your customers, your business and your future. The information you provide to register is confidential and will not be shared.
Thank you for taking the time to get involved and to participate in HDMAVotes. 
John M. Gray
President and CEO
Take Action
Legislative Tracking
- S. 733: A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
- H.R. 2245: Preserving Access to Life-Saving Medications Act of 2011
- S. 319: Pharmaceutical Market Access and Drug Safety Act of 2011
- H.R. 2495: Tax Equity and Middle Class Fairness Act of 2011
- S. 1002: SAFE DOSES Act
- H.R. 1065: Pill Mill Crackdown Act of 2011
- S. 296: Preserving Access to Life-Saving Medications Act
- H.R. 905: To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.